Bio-Path Holdings, Inc.盘中异动早盘急速下跌7.45%报1.38美元

市场透视12-20 22:30

北京时间2024年12月20日22时30分，Bio-Path Holdings, Inc.（BPTH.us）股票出现异动，股价急速下挫7.45%。截至发稿，该股报1.38美元/股，成交量107.787万股，换手率25.03%，振幅3.96%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.12百万美元，每股收益-0.70美元，毛利-33000.00美元，市盈率-0.17倍。机构评级...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2492442600?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-20 22:30","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2492442600","market":"us","top_or_hot":-1,"title":"Bio-Path Holdings, Inc.盘中异动 早盘急速下跌7.45%报1.38美元","media":"市场透视","content":"<div>\n<p>北京时间2024年12月20日22时30分，Bio-Path Holdings, Inc.（BPTH.us）股票出现异动，股价急速下挫7.45%。截至发稿，该股报1.38美元/股，成交量107.787万股，换手率25.03%，振幅3.96%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.12百万美元，每股收益-0.70美元，毛利-33000.00美元，市盈率-0.17倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223023984cfbe1&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bio-Path Holdings, Inc.盘中异动 早盘急速下跌7.45%报1.38美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBio-Path Holdings, Inc.盘中异动 早盘急速下跌7.45%报1.38美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-20 22:30 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223023984cfbe1&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年12月20日22时30分，Bio-Path Holdings, Inc.（BPTH.us）股票出现异动，股价急速下挫7.45%。截至发稿，该股报1.38美元/股，成交量107.787万股，换手率25.03%，振幅3.96%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.12百万美元，每股收益-0.70美元，毛利-33000.00美元，市盈率-0.17倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223023984cfbe1&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223023984cfbe1&s=b","article_id":"2492442600","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223023984cfbe1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2492442600","pubTimestamp":1734705023,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年12月20日22时30分，Bio-Path Holdings, Inc.股票出现异动，股价急速下挫7.45%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Humacyte, Inc.、Psyence Biomedical Ltd.、Aptose Biosciences, Inc.涨幅较大，Psyence Biomedical Ltd.、Aptose Biosciences, Inc.、Aditxt, Inc.较为活跃，换手率分别为1707.42%、76.55%、53.88%，振幅较大的相关个股有Polyrizon Ltd.、Aptose Biosciences, Inc.、冠科美博，振幅分别为6.21%、5.88%、5.34%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","BPTH":"Bio-Path Holdings, Inc."},"translate_title":"Bio-Path Holdings, Inc. fell sharply 7.45% to $1.38 in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BPTH":1},"content_text":"北京时间2024年12月20日22时30分，Bio-Path Holdings, Inc.（BPTH.us）股票出现异动，股价急速下挫7.45%。截至发稿，该股报1.38美元/股，成交量107.787万股，换手率25.03%，振幅3.96%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.12百万美元，每股收益-0.70美元，毛利-33000.00美元，市盈率-0.17倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Humacyte, Inc.、Psyence Biomedical Ltd.、Aptose Biosciences, Inc.涨幅较大，Psyence Biomedical Ltd.、Aptose Biosciences, Inc.、Aditxt, Inc.较为活跃，换手率分别为1707.42%、76.55%、53.88%，振幅较大的相关个股有Polyrizon Ltd.、Aptose Biosciences, Inc.、冠科美博，振幅分别为6.21%、5.88%、5.34%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc 是一家专注于临床和临床前阶段肿瘤学的 RNAi 纳米颗粒药物开发公司。 它致力于利用一项新技术，用以实现对疾病中过度表达的任何基因产物的靶标特异性蛋白质抑制的系统递送。 该公司的候选药物 prexigebersen 正处于与低剂量阿糖胞苷（LDAC）联合治疗以及与地西他滨联合治疗急性髓性白血病（AML）的 2 期临床试验的疗效部分。 该公司的其他药物有BP1002、BP1003、BP1001-A和DNABILIZE。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2492442600"}

Bio-Path Holdings, Inc.盘中异动 早盘急速下跌7.45%报1.38美元

精彩评论

Bio-Path Holdings, Inc.盘中异动早盘急速下跌7.45%报1.38美元